AC Immune (ACIU) Reports Q3 Loss, Lags Revenue Estimates

AC Immune (ACIU) came out with a quarterly loss of $0.2 per share versus the Zacks Consensus Estimate of a loss of $0.22. This compares to earnings of $0.06 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +9.09%. A quarter ago, it was expected that this biopharmaceutical company would post a loss of $0.2 per share when it actually produced a loss of $0.25, delivering a surprise of -25%.Over the last four quarters, the company ...